MBP metabolic pharmaceuticals limited

the trial, page-3

  1. 3,690 Posts.
    Truth,

    From my understanding the first trial was hopelessly designed and executed. In fact it was so bad that it didn't reduce or block out the major variables of exercise and diet. Therefore the whole trial was meaningless and had to be repeated.

    The second trial which was much better designed proved that the drug was ineffective.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.